106 related articles for article (PubMed ID: 15006930)
1. No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer.
Li L; Cicek MS; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):497-8. PubMed ID: 15006930
[No Abstract] [Full Text] [Related]
2. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
[TBL] [Abstract][Full Text] [Related]
3. IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly.
Akin F; Turgut S; Cirak B; Kursunluoglu R
Growth Horm IGF Res; 2010 Dec; 20(6):399-403. PubMed ID: 20920870
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
[TBL] [Abstract][Full Text] [Related]
5. IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer.
Friedrichsen DM; Hawley S; Shu J; Humphrey M; Sabacan L; Iwasaki L; Etzioni R; Ostrander EA; Stanford JL
Prostate; 2005 Sep; 65(1):44-51. PubMed ID: 15800934
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
7. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I gene and insulin-like growth factor binding protein-3 polymorphism in patients with thyroid dysfunction.
Kursunluoglu R; Turgut S; Akin F; Bastemir M; Kaptanoglu B; Genc O; Turgut G
Arch Med Res; 2009 Jan; 40(1):42-7. PubMed ID: 19064126
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
[TBL] [Abstract][Full Text] [Related]
11. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men.
Kehinde EO; Akanji AO; Mojiminiyi OA; Bashir AA; Daar AS; Varghese R
Prostate Cancer Prostatic Dis; 2005; 8(1):84-90. PubMed ID: 15775992
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
Diorio C; Brisson J; Bérubé S; Pollak M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ER-alpha polymorphisms and the intrafollicular IGF system for predicting pregnancy in IVF-ET patients.
Choi YS; Kim SH; Ku SY; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY
Gynecol Obstet Invest; 2009; 67(2):73-80. PubMed ID: 18843190
[TBL] [Abstract][Full Text] [Related]
15. Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.
Tsuchiya N; Wang L; Suzuki H; Segawa T; Fukuda H; Narita S; Shimbo M; Kamoto T; Mitsumori K; Ichikawa T; Ogawa O; Nakamura A; Habuchi T
J Clin Oncol; 2006 May; 24(13):1982-9. PubMed ID: 16648498
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
Nam RK; Trachtenberg J; Jewett MA; Toi A; Evans A; Emami M; Narod SA; Pollak M
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1270-3. PubMed ID: 15894684
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk.
Neuhausen SL; Slattery ML; Garner CP; Ding YC; Hoffman M; Brothman AR
Prostate; 2005 Jul; 64(2):168-74. PubMed ID: 15678496
[TBL] [Abstract][Full Text] [Related]
18. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
[TBL] [Abstract][Full Text] [Related]
20. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
Oliver SE; Holly J; Peters TJ; Donovan J; Persad R; Gillatt D; Pearce A; Hamdy FC; Neal DE; Gunnell D
Urology; 2004 Aug; 64(2):317-22. PubMed ID: 15302487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]